A change in strategy: The use of regenerative medicine and tissue engineering to augment the course of intervertebral disc degeneration

Operative Techniques in Orthopaedics

Volumn 20, Issue 2, 2010, Pages 144-153

  Woods, Barrett I ^a   Sowa, Gwendolyn ^a   Vo, Nam ^a   Kang, James D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Degenerative disc disease; Gene therapy; Scaffolds; Stem cells; Tissue engineering

Indexed keywords

ADENOVIRUS VECTOR; ALGINIC ACID; ALGINIC ACID PROPYLENE GLYCOL ESTER; ANTIINFLAMMATORY AGENT; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COLLAGEN; COLLAGEN FIBER; FIBRIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; POLYGLYCOLIC ACID; PROTEOGLYCAN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BACKACHE; BIOENGINEERING; BIOMECHANICS; BONE STRUCTURE; CARTILAGE; GENE THERAPY; HUMAN; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; NUCLEUS PULPOSUS; PHYSIOTHERAPY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RISK FACTOR; SILK; SPINE FUSION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77953349470     PISSN: 10486666     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.oto.2009.10.009     Document Type: Article

References (66)

1. Lively M.W. Sports medicine approach to low back pain. South Med J 2002, 95:642-646.
2. Maetzel A., Li L. The economic burden of low back pain: A review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 2002, 16:23-30.
3. Luo X., Pietrobon R., Sun S.X., et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 2004, 29:79-86.
4. Freimark D., Czermak P. Cell-based regeneration of intervertebral disc defects: Review and concepts. Int J Artif Organs 2009, 32:197-203.
5. Vanharanta H., Sachs B.L., Spivey M.A., et al. The relationship of pain provocation to lumbar disc deterioration as seen by CT/discography. Spine 1987, 12:295-298.
6. Hubert M.G., Vadala G., Sowa G., et al. Gene therapy for the treatment of degenerative disk disease. J Am Acad Orthop Surg 2008, 16:312-319.
7. Fassett D.R., Kurd M.F., Vaccaro A.R. Biologic solutions for degenerative disk disease. J Spinal Disord Tech 2009, 22:297-308.
8. Colombini A., Lombardi G., Corsi M.M., et al. Pathophysiology of the human intervertebral disc. Int J Biochem Cell Biol 2008, 40:837-842.
9. Lotz J.C., Hsieh A.H., Walsh A.L., et al. Mechanobiology of the intervertebral disc. Biochem Soc Trans 2002, 30:853-858.
10. Jahnke M.R., McDevitt C.A. Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Biochem J 1988, 251:347-356.
11. Sive J.I., Baird P., Jeziorsk M., et al. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 2002, 55:91-97.
12. Guehring T., Wilde G., Sumner M., et al. Notochordal intervertebral disc cells: Sensitivity to nutrient deprivation. Arthritis Rheum 2009, 60:1026-1034.
13. Ambard D., Cherblanc F. Mechanical behavior of annulus fibrosus: A microstructural model of fiber's reorientation. Ann Biomed Eng 2009, 37:2256-2265.
14. Bruehlmann S.B., Rattner J.B., Matyas J.R., et al. Regional variations in the cellular matrix of the annulus fibrosus of the intervertebral disc. J Anat 2002, 201:159-171.
15. Butler D., Trafimow J.H., Andersson G.B., et al. Discs degenerate before facets. Spine 1990, 15:111-113.
16. Grunhagen T., Wilde G., Soukane D.M., et al. Nutrient supply and intervertebral disc metabolism. J Bone Joint Surg Am 2006, 88(suppl 2):30-35.
17. Herkowitz H.N., Rothman R.H., Simeone F.A. Rothman-Simeone The Spine 2006, Saunders Elsevier, Philadelphia, PA. ed 5.
18. Bibby S.R., Jones D.A., Ripley R.M., et al. Metabolism of the intervertebral disc: Effects of low levels of oxygen, glucose, and pH on rates of energy metabolism of bovine nucleus pulposus cells. Spine 2005, 30:487-496.
19. Ishihara H., Urban J.P. Effects of low oxygen concentrations and metabolic inhibitors on proteoglycan and protein synthesis rates in the intervertebral disc. J Orthop Res 1999, 17:829-835.
20. Ghosh P. The Biology of the Intervertebral Disc 1988, CRC Press, Boca Raton, FL.
21. Richardson S.M., Mobasheri A., Freemont A.J., et al. Intervertebral disc biology, degeneration and novel tissue engineering and regenerative medicine therapies. Histol Histopathol 2007, 22:1033-1041.
22. Urban J.P., Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther 2003, 5:120-130.
23. Melrose J., Ghosh P., Taylor T.K. A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the intervertebral disc. J Anat 2001, 198:3-15.
24. Haefeli M., Kalberer F., Saegesser D., et al. The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine 2006, 31:1522-1531.
25. Scapinelli R. Lumbar disc herniation in eight siblings with a positive family history for disc disease. Acta Orthop Belg 1993, 59:371-376.
26. Varlotta G.P., Brown M.D., Kelsey J.L., et al. Familial predisposition for herniation of a lumbar disc in patients who are less than twenty-one years old. J Bone Joint Surg Am 1991, 73:124-128.
27. Matsui H., Kanamori M., Ishihara H., et al. Familial predisposition for lumbar degenerative disc disease: A case-control study. Spine 1998, 23:1029-1034.
28. Kim P.K., Branch C.L. The lumbar degenerative disc: Confusion, mechanics, management. Clin Neurosurg 2006, 53:18-25.
29. Hasegawa T., An H.S., Haughton V.M., et al. Lumbar foraminal stenosis: Critical heights of the intervertebral discs and foramina. A cryomicrotome study in cadavera. J Bone Joint Surg Am 1995, 77:32-38.
30. Bullough P.G. Orthopaedic Pathology 2004, Mosby, Edinburgh, UK. ed 4.
31. McGuirk B., King W., Govind J., et al. Safety, efficacy, and cost effectiveness of evidence-based guidelines for the management of acute low back pain in primary care. Spine 2001, 26:2615-2622.
32. Putzier M., Schneider S.V., Funk J.F., et al. The surgical treatment of the lumbar disc prolapse: Nucleotomy with additional transpedicular dynamic stabilization versus nucleotomy alone. Spine 2005, 30:E109-E114.
33. Javedan S.P., Dickman C.A. Cause of adjacent-segment disease after spinal fusion. Lancet 1999, 354:530-531.
34. Okuda S., Iwasaki M., Miyauchi A., et al. Risk factors for adjacent segment degeneration after PLIF. Spine 2004, 29:1535-1540.
35. Levin D.A., Hale J.J., Bendo J.A. Adjacent segment degeneration following spinal fusion for degenerative disc disease. Bull NYU Hosp Jt Dis 2007, 65:29-36.
36. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1981, 1:75-78.
37. Cao Y., Vacanti J.P., Paige K.T., et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 1997, 100:297-302. discussion 3-4.
38. Rotter N., Bonassar L.J., Tobias G., et al. Age dependence of biochemical and biomechanical properties of tissue-engineered human septal cartilage. Biomaterials 2002, 23:3087-3094.
39. Kojima K., Bonassar L.J., Roy A.K., et al. Autologous tissue-engineered trachea with sheep nasal chondrocytes. J Thorac Cardiovasc Surg 2002, 123:1177-1184.
40. Luk K.D., Ruan D.K., Chow D.H., et al. Intervertebral disc autografting in a bipedal animal model. Clin Orthop Relat Res 1997, 13-26.
41. Li W.J., Jiang Y.J., Tuan R.S. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng 2006, 12:1775-1785.
42. Chang G., Kim H.J., Kaplan D., et al. Porous silk scaffolds can be used for tissue engineering annulus fibrosus. Eur Spine J 2007, 16:1848-1857.
43. Roughley P., Hoemann C., DesRosiers E., et al. The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials 2006, 27:388-396.
44. Gruber H.E., Leslie K., Ingram J., et al. Cell-based tissue engineering for the intervertebral disc: In vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J 2004, 4:44-55.
45. Mizuno H., Roy A.K., Vacanti C.A., et al. Tissue-engineered composites of anulus fibrosus and nucleus pulposus for intervertebral disc replacement. Spine 2004, 29:1290-1297. discussion 7-8.
46. Kandel R., Roberts S., Urban J.P. Tissue engineering and the intervertebral disc: The challenges. Eur Spine J 2008, 17(suppl 4):480-491.
47. Seguin C.A., Grynpas M.D., Pilliar R.M., et al. Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine 2004, 29:1299-1306. discussion 306-307.
48. Waldman S.D., Grynpas M.D., Pilliar R.M., et al. Characterization of cartilagenous tissue formed on calcium polyphosphate substrates in vitro. J Biomed Mater Res 2002, 62:323-330.
49. Hiyama A., Mochida J., Iwashina T., et al. Transplantation of mesenchymal stem cells in a canine disc degeneration model. J Orthop Res 2008, 26:589-600.
50. Sobajima S., Vadala G., Shimer A., et al. Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J 2008, 8:888-896.
51. Sakai D., Mochida J., Iwashina T., et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: Potential and limitations for stem cell therapy in disc regeneration. Spine 2005, 30:2379-2387.
52. Vadala G., Studer R.K., Sowa G., et al. Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion. Spine 2008, 33:870-876.
53. Aguiar D.J., Johnson S.L., Oegema T.R. Notochordal cells interact with nucleus pulposus cells: Regulation of proteoglycan synthesis. Exp Cell Res 1999, 246:129-137.
54. Meisel H.J., Siodla V., Ganey T., et al. Clinical experience in cell-based therapeutics: Disc chondrocyte transplantation: A treatment for degenerated or damaged intervertebral disc. Biomol Eng 2007, 24:5-21.
55. Nomura T., Mochida J., Okuma M., et al. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res 2001, 94-101.
56. Nishida K., Kang J.D., Gilbertson L.G., et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 1999, 24:2419-2425.
57. Moon S.H., Nishida K., Gilbertson L.G., et al. Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine 2008, 33:1850-1855.
58. Wallach C.J., Sobajima S., Watanabe Y., et al. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine 2003, 28:2331-2337.
59. Le Maitre C.L., Freemont A.J., Hoyland J.A. A preliminary in vitro study into the use of IL-1RA gene therapy for the inhibition of intervertebral disc degeneration. Int J Exp Pathol 2006, 87:17-28.
60. Le Maitre C.L., Freemont A.J., Hoyland J.A. Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 2007, 9:R45.
61. Kauppila L.I. Ingrowth of blood vessels in disc degeneration. Angiographic and histological studies of cadaveric spines. J Bone Joint Surg Am 1995, 77:26-31.
62. Harrison P.E., Ashton I.K., Johnson W.E., et al. The in vitro growth of human chondrocytes. Cell Tissue Bank 2000, 1:255-260.
63. Risbud M.V., Albert T.J., Guttapalli A., et al. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: Implications for cell-based transplantation therapy. Spine 2004, 29:2627-2632.
64. Sobajima S., Kompel J.F., Kim J.S., et al. A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine 2005, 30:15-24.
65. Sobajima S., Shimer A.L., Chadderdon R.C., et al. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J 2005, 5:14-23.
66. Hamilton D.J., Seguin C.A., Wang J., et al. Formation of a nucleus pulposus-cartilage endplate construct in vitro. Biomaterials 2006, 27:397-405.